Twelfth scientific biennial meeting of the Australasian Virology Society: AVS12 2024

Ebony A. Monson, Robson K. Loterio, Justin A. Roby, Anurag Adhikari, Rowena A. Bull, Jill M. Carr, Demetra S.M. Chatzileontiadou, Colin X. Cheng, Fasséli Coulibaly, Samantha K. Davis, Joshua M. Deerain, Mark W. Douglas, Heidi E. Drummer, Nicholas S. Eyre, Wesley Freppel, Anjali Gowripalan, Emma J. Grant, Stephanie Gras, Jenna J. Guthmiller, Lara J. HerreroEva Hesping, Bethany A. Horsburgh, Jennifer L. Hyde, Marios Koutsakos, Jason M. Mackenzie, Jackie E. Mahar, Laura C. McCoullough, Christopher L.D. McMillan, Naphak Modhiran, Rhys H. Parry, Damian F.J. Purcell, Daniel J. Rawle, Andrii Slonchak, Peter G. Speck, Gilda Tachedjian, Thomas Tu, Gregory W. Moseley, Johanna E. Fraser, Michelle D. Tate

Research output: Contribution to journalReview ArticleOtherpeer-review

Abstract

The Australasian Virology Society (AVS) holds premier biennial virology meetings that foster multidisciplinary research and collaboration and promote equity and inclusion of early-career researchers. The 12th AVS meeting (AVS12), convened by M. Tate, J. Fraser, and G. Moseley, was held from 2 to 5 December 2024 on Dja Dja Wurrung country at the RACV Goldfields Resort in Creswick, Victoria, Australia. In this report, we give a brief overview of the history of AVS and outline the current and developing priorities for the society. We provide a summary of the insightful panel discussions held to address career development and Indigenous virology, highlight the presentations given by international plenary speakers Joe Grove and Chantal Abergel, and celebrate the recipients of the numerous awards.

Original languageEnglish
Article numbere02255-24
Number of pages14
JournalJournal of Virology
Volume99
Issue number5
DOIs
Publication statusPublished - May 2025

Keywords

  • animal viruses
  • antivirals
  • bacteriophages
  • clinical virology
  • epidemiology
  • immunology
  • innate immunity
  • vaccines
  • virus-host interactions

Cite this